Search research articles
Contact Us
Filters
Showing results (1-10 of 339) with videos related to
Page
of 34
Sort By:
Annals of Internal Medicine
|
July 17, 2023
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
Dimitrios Patoulias
Acta Cardiologica Sinica
|
May 12, 2021
SGLT-2 Inhibitors Beneficial Effects on Ventricular Repolarization May Be Protective against Atrial Fibrillation Occurrence
Dimitrios Patoulias
Critical Care (London, England)
|
May 26, 2023
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
Dimitrios Patoulias
Acta Medica (Hradec Kralove)
|
May 3, 2018
SGLT-2 Inhibitors: Are They a Promising Treatment Option in T2DM Patients with NAFLD?
Dimitrios Patoulias
Journal of Clinical and Translational Hepatology
|
August 27, 2021
Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
Dimitrios Patoulias
Polish Archives of Internal Medicine
|
August 22, 2022
Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers?
Dimitrios Patoulias
Annals of the Rheumatic Diseases
|
January 14, 2022
Correspondence on 'Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors'
Dimitrios Patoulias
Chest
|
November 9, 2023
Corticosteroids for Community-Acquired Pneumonia: Time to Teach an Old Dog (Hydrocortisone) New Tricks?
Dimitrios Patoulias
European Journal of Internal Medicine
|
January 7, 2023
Anakinra for macrophage activation syndrome
Dimitrios Patoulias
The New England Journal of Medicine
|
December 6, 2023
Randomized Trial of Pegozafermin in NASH
Dimitrios Patoulias
Page
of 34
Search research articles
Search
Showing results (1-10 of 339) with videos related to
Sort By:
Page
of 34
Annals of Internal Medicine
|
July 17, 2023
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
Dimitrios Patoulias
Acta Cardiologica Sinica
|
May 12, 2021
SGLT-2 Inhibitors Beneficial Effects on Ventricular Repolarization May Be Protective against Atrial Fibrillation Occurrence
Dimitrios Patoulias
Critical Care (London, England)
|
May 26, 2023
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
Dimitrios Patoulias
Acta Medica (Hradec Kralove)
|
May 3, 2018
SGLT-2 Inhibitors: Are They a Promising Treatment Option in T2DM Patients with NAFLD?
Dimitrios Patoulias
Journal of Clinical and Translational Hepatology
|
August 27, 2021
Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
Dimitrios Patoulias
Polish Archives of Internal Medicine
|
August 22, 2022
Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers?
Dimitrios Patoulias
Annals of the Rheumatic Diseases
|
January 14, 2022
Correspondence on 'Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors'
Dimitrios Patoulias
Chest
|
November 9, 2023
Corticosteroids for Community-Acquired Pneumonia: Time to Teach an Old Dog (Hydrocortisone) New Tricks?
Dimitrios Patoulias
European Journal of Internal Medicine
|
January 7, 2023
Anakinra for macrophage activation syndrome
Dimitrios Patoulias
The New England Journal of Medicine
|
December 6, 2023
Randomized Trial of Pegozafermin in NASH
Dimitrios Patoulias
Page
of 34